SUNPHARMA delivered a respectable weekly return of 2.89%, outperforming HINDUNILVR but lagging behind DRREDDY and DIVISLAB. The stock's volatility of 14.26% was moderate, indicating a relatively stable performance. With a Sharpe Ratio of 0.80, SUNPHARMA's return was decent considering the risk taken. Overall, the stock's performance was decent, but it didn't stand out among its peers.

[Volatility: 14.26%]